Suicide widow sues Pfizer over Chantix

It had to happen sometime: The widow of a man who committed suicide in January has sued Pfizer, alleging that the drugmaker should have warned Chantix patients sooner about its psychiatric side effects. Report

Suggested Articles

Pfizer’s Ibrance has met with success in breast cancer since breaking onto the scene in 2015. But its first foray into early breast cancer was a bust.

After years of having first-line liver cancer market to itself, Bayer’s Nexavar is getting major competition from Roche's Tecentriq.

Most of the recent enthusiasm around AbbVie’s new drugs has centered on Skyrizi and Rinvoq, but elagolix wants a piece of the spotlight, too.